Abstract
BackgroundThe presence of tertiary lymphoid structures (TLS) has been associated with improved response to immune checkpoint blockade (ICB) treatment in several indications including non-small cell lung and bladder cancers, sarcomas,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
